|
CA2884676A1
|
|
Processes for the preparation of 3-alkyl indoles
|
|
WO2013185211A1
|
|
Polymorphic forms of rifaximin
|
|
CA2812490A1
|
|
1,3-oxathiolane derivatives, process for the preparation of 1,3-oxathiolane derivatives and intermediates thereof
|
|
US2013072680A1
|
|
Processes for the preparation of rivaroxaban and intermediates thereof
|
|
WO2013026149A1
|
|
Dimethyl-(3,3-difluoro-2,2-dihydroxyheptyl)phosphonate and processes for its preparation
|
|
EP2655364A1
|
|
A process for the preparation of lapatinib and its ditosylate salt
|
|
CA2802874A1
|
|
Polymorphic forms of rifaximin
|
|
CA2800016A1
|
|
Polymorphic forms of warfarin potassium and preparations thereof
|
|
CA2797090A1
|
|
Polymorphic forms of lapatinib ditosylate and processes for their preparation
|
|
EP2536705A1
|
|
Polymorphic forms of lubiprostone
|
|
WO2011072383A1
|
|
Processes for the purification of lubiprostone
|
|
CA2815063A1
|
|
Processes for the preparation of rivaroxaban and intermediates thereof
|
|
CA2750487A1
|
|
Methods of making lubiprostone and intermediates thereof
|
|
WO2010040212A1
|
|
Processes for the preparation of erlotinib hydrochloride
|
|
AU2009212902A1
|
|
Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
|
|
US7816355B1
|
|
Processes for the preparation of rivaroxaban and intermediates thereof
|
|
US2010168111A1
|
|
Polymorphic form of 5 chloro n {[(5s) 2 oxo 3 [4 (3 oxomorpholin 4 yl)phenyl]oxa-zolidin 5 yl]-methyl}thiophene 2 carboxamide
|
|
WO2008151430A1
|
|
Novel processes to form-i of olanzapine
|
|
US2009247749A1
|
|
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
|
|
US2009082558A1
|
|
Amorphous form of rifaximin and processes for its preparation
|
